BioWorld MedTech

March 31, 2016

View Archived Issues

Start-up Medicortex taking on TBI in dual drug-biomarker approach

Read More

Fujifilm developing photo technology into regenerative therapy

Read More

Upton: Is U.S. prepared to test millions of pregnant women for Zika?

Read More

Other news to note

Read More

Daily M&A

Read More

Appointments and advancements

Read More

Financings

Read More

product briefs

Read More

MDD's Orthopedics Extra

Read More

Diasorin to acquire Focus assets from Quest Diagnostics for $300 million

Saluggia, Italy-based, Diasorin S.p.A. said it will acquire Focus Diagnostics Inc.'s immunodiagnostic and molecular diagnostic products for $300 million in cash from Madison, N.J.-based, Quest Diagnostics Inc. Read More

House members prod CMS to delay lab fee overhaul until 2018

Read More